Abbott clinical biochemical total bilirubin test group
Taiwan·Risk Class 2·ABBOTT GMBH;; SEKISUI DIAGNOSTICS P.E.I. INC.·Registered Jun 05, 2007 – Jun 05, 2027Active- Analysis ID
- 10ef7448304caa0a9099bc8a887c9af1
- Customs Code
- DHA00601827700
- Manufacturer
- ABBOTT GMBH;; SEKISUI DIAGNOSTICS P.E.I. INC.
- Manufacturer Country
- Canada;;Germany
- Authorized Representative
- ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.)
- Intended Use
- Quantitative testing of total bilirubin in serum or plasma of adults and newborns.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1110 Bilirubin (total or direct) test system
- Import Information
- Contract manufacturing;; input
- Registration Date
- Jun 05, 2007
- Expiry Date
- Jun 05, 2027
Top companies providing products similar to "Abbott clinical biochemical total bilirubin test group"
Recently registered similar products
Access comprehensive regulatory information for Abbott clinical biochemical total bilirubin test group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 10ef7448304caa0a9099bc8a887c9af1 and manufactured by ABBOTT GMBH;; SEKISUI DIAGNOSTICS P.E.I. INC.. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including ABBOTT LABORATORIES, and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.